Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Basal thumb osteoarthritis injection trial
ACTRN12620000732987Phase 4Not yet recruiting
- Sponsor
- Prof. Warren Rozen
- Start
- Oct 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of hyaluronic acid, methylprednisolone and sodium chloride in Rhizarthrosis (3 arms), sponsored by Prof. Warren Rozen. Primary endpoints: Change in pain of the affected hand at 26 weeks, Patient Global Assessment score at 26 weeks and 1 more. Planned start Oct 2020; status: not yet recruiting.
02
Drugs
hyaluronic acidmethylprednisolonesodium chloride
03
Conditions
Rhizarthrosis
Beyond the preview
Go deeper on ACTRN12620000732987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12620000732987.